Skip to main content
Veterinary Medicines

Rabadrop, Oral suspension

Authorised
  • Rabies virus, strain SAD, Live

Product identification

Medicine name:
Rabadrop, Oral suspension
RABADROP, oralna suspenzija
Active substance:
  • Rabies virus, strain SAD, Live
Target species:
  • Fox
  • Raccoon dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Rabies virus, strain SAD, Live
    8.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Fox
    • Raccoon dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07BD
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:
  • Plastic Sachet 2 x 350.0 Dose
  • Plastic Sachet 1 x 700.0 Dose
  • Plastic Sachet 1 x 30.0 Dose
  • Paper Box 30 x 20.0 Dose
  • Paper Box 1 x 20.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/19-01/467
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0149/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 30/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."